China Biopharmaceutical and Pharmaceutical Regulatory Framework Reforms
16 Mar 2017
The China Food and Drug Administration has noted a number of reforms to biopharmaceutical and pharmaceutical policy frameworks, aiming to encourage development, approval, and manufacture of required therapies.
IMS Market Prognosis Summary
09 Mar 2017
IMS Health and CPHI China provide a market overview and forecasts for 2016-2020.